Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Evotec Achieves UCB Milestones | Contract Pharma

What are you searching for?

Sign in
Breaking News

Evotec Achieves UCB Milestones

Projects move into hit-to-lead and lead optimization

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Evotec AG has achieved its first milestones in its multi-target drug discovery collaboration with UCB in the field of immunology. The milestones included the progression of certain projects into hit-to-lead and lead optimization. Financial terms were not disclosed.
 
Under the collaboration, entered in October 2011, Evotec receives research payments and preclinical, clinical, and sales milestones, as well as royalties on product sales.
 
Dr. Mario Polywka, chief operating officer of Evotec, said, “We are delighted that the project teams at UCB and Evotec have met these important milestones in the collaboration. The progress in this collaboration is a testament to the way scientists from both companies have worked together in a true partnership.”
 
Dr. Neil Weir, senior vice president of Discovery at UCB, said, “The collaboration with Evotec complements our internal research efforts and enhances our scientific network. Hitting these milestones is great news and as we continue to work together, we hope that the results will enhance the pace of the discovery process, the quality of compounds selected for further development and ultimately improve patient outcomes.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics